1. Chan JK, Quintanilla-Martinez L, Ferry JA, Peh SC . Extranodal NK/T-cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NL et al. (eds) WHO classification of tumours of haematopoeitic and lymphoid tissue. International Agency for Research on Cancer: Lyon, 2008; pp 285–288.
2. Chan JK, Jaffe ES, Ralfkiaer E, Ko YH . Aggresssive NK cell leukaemia. In Swerdlow SH, Campo E, Harris NL et al. (eds) WHO classification of tumours of haematopoeitic and lymphoid tissue. International Agency for Research on Cancer: Lyon, 2008; pp 276–277.
3. Kwong YL . Natural killer-cell malignancies: diagnosis and treatment. Leukemia 2005; 19: 2186–2194.
4. Ishida F, Kwong YL . Diagnosis and management of natural killer-cell malignancies. Expert Rev Hematol 2010; 3: 593–602.
5. Yamaguchi M, Suzuki R, Kwong YL, Kim WS, Hasegawa Y, Izutsu K et al. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 2008; 99: 1016–1020.